1. A condensed cyclic compound represented by Formula 1 below:
wherein in Formula 1,
X1 is -(L1)a1-N(Ar1)(Ar2);
X2 is -(L2)a2-N(Ar3)(Ar4);
X3 is -(L3)a3-N(Ar5)(Ar6);
X4 is -(L4)a4-N(Ar7)(Ar8) or R4;
L1 to L4 are each independently selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C2-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C2-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C60 arylene group, a substituted or unsubstituted C2-C60 heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group;
a1 to a4 are each independently selected from 0, 1, 2, and 3;
Ar1 to Ar8 are each independently selected from a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C2-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C2-C60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group;
b1 and b2 are each independently an integer selected from 0 to 4, b3 is an integer selected from 0 to 3, i) when X4 is R4, b1+b2+b3\u22672, and ii) when X4 is -(L4)a4-N(Ar7)(Ar5), b1+b2+b3\u22671;
R1 to R6 are each independently selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C2-C60 alkenyl group, a substituted or unsubstituted C2-C60 alkynyl group, a substituted or unsubstituted C1-C60 alkoxy group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C2-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C6-C60 aryloxy group, a substituted or unsubstituted C6-C60 arylthio group, a substituted or unsubstituted C2-C60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, \u2014Si(Q1)(Q2)(Q3), and \u2014B(Q4)(Q5);
c1 and c2 are each independently an integer selected from 0 to 4, and c3 is an integer selected from 0 to 3;
at least one of substituents of the substituted C3-C10 cycloalkylene group, the substituted C2-C10 heterocycloalkylene group, the substituted C3-C10 cycloalkenylene group, the substituted C2-C10 heterocycloalkenylene group, the substituted C6-C60 arylene group, the substituted C2-C60 heteroarylene group, the substituted divalent non-aromatic condensed polycyclic group, the substituted divalent non-aromatic condensed heteropolycyclic group, the substituted C1-C60 alkyl group, the substituted C2-C60 alkenyl group, the substituted C2-C60 alkynyl group, the substituted C1-C60 alkoxy group, the substituted C3-C10 cycloalkyl group, the substituted C2-C10 heterocycloalkyl group, the substituted C3-C10 cycloalkenyl group, the substituted C2-C10 heterocycloalkenyl group, the substituted C6-C60 aryl group, the substituted C6-C60 aryloxy group, the substituted C6-C60 arylthio group, the substituted C2-C60 heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is selected from
a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C1-C60 alkoxy group;
a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, or a C1-C60 alkoxy group, each substituted at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C3-C10 cycloalkyl group, a C2-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C2-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C2-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, \u2014Si(Q11)(Q12)(Q13), \u2014B(Q14)(Q15), and \u2014N(Q16)(Q17);
a C3-C10 cycloalkyl group, a C2-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C2-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C2-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group;
a C3-C10 cycloalkyl group, a C2-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C2-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C2-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, or a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10 cycloalkyl group, a C2-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C2-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C2-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, \u2014Si(Q21)(Q22)(Q23), \u2014B(Q24)(Q25), and \u2014N(Q26)(Q27); and
\u2014Si(Q31)(Q32)(Q33), \u2014B(Q34)(Q35), and \u2014N(Q36)(Q37);
wherein Q1 to Q5, Q11 to Q17, Q21 to Q27, and Q31 to Q37 are each independently a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10 cycloalkyl group, a C2-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C2-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C2-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, or a monovalent non-aromatic condensed heteropolycyclic group.
2. The condensed cyclic compound as claimed in claim 1, wherein
L1 to L4 in Formula 1 are each independently selected from
a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-fluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a rubicenylene group, a coronenylene group, an ovalenylene group, a pyrrolylene group, a thiophenylene group, a furanylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzoimidazolylene group, a benzofuranylene group, a benzothiophenylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an oxadiazolylene group, a triazinylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a thiadiazolylene group, an imidazopyridinylene group, and an imidazopyrimidinylene group; and
a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-fluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a rubicenylene group, a coronenylene group, an ovalenylene group, a pyrrolylene group, a thiophenylene group, a furanylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzoimidazolylene group, a benzofuranylene group, a benzothiophenylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an oxadiazolylene group, a triazinylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a thiadiazolylene group, an imidazopyridinylene group, and an imidazopyrimidinylene group, each substituted with at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a phenylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group.
3. The condensed cyclic compound as claimed in claim 1, wherein
L1 to L4 in Formula 1 are each independently represented by any one of Formulae 3-1 to 3-32:
wherein in Formulae 3-1 to 3-32,
Y1 is O, S, C(Z3)(Z4), N(Z5), or Si(Z6)(Z7);
Z1 to Z7 are each independently selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and a triazinyl group;
d1 is an integer selected from 1 to 4;
d2 is an integer selected from 1 to 3;
d3 is an integer selected from 1 to 6;
d4 is an integer selected from 1 to 8;
d5 is 1 or 2;
d6 is an integer selected from 1 to 5; and
* and *\u2032 each indicate a binding site with an adjacent atom.
4. The condensed cyclic compound as claimed in claim 1, wherein
L1 to L4 in Formula 1 are each independently represented by any one of Formulae 4-1 to 4-23:
in Formulae 4-1 to 4-23, * and *\u2032 each indicate a binding site with an adjacent atom.
5. The condensed cyclic compound as claimed in claim 1, wherein
a1 to a4 in Formula 1 are each independently 0 or 1.
6. The condensed cyclic compound as claimed in claim 1, wherein
Ar1 to Ar8 in Formula 1 are each independently selected from
a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group; and
a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group, each substituted with at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and \u2014Si(Q31)(Q32)(Q33);
wherein Q31 to Q33 are each independently selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and a triazinyl group.
7. The condensed cyclic compound as claimed in claim 1, wherein
Ar1 to Ar8 in Formula 1 are each independently selected from
a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a triazinyl group a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, and a dibenzocarbazolyl group; and
a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a triazinyl group a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, and a dibenzocarbazolyl group, each substituted with at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a triazinyl group a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, and \u2014Si(Q31)(Q32)(Q33),
wherein Q31 to Q33 are each independently selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and a triazinyl group.
8. The condensed cyclic compound as claimed in claim 1, wherein
Ar1 to Ar8 in Formula 1 are each independently selected from Formulae 5-1 to 5-14:
wherein Formulae 5-1 to 5-14,
Y31 is O, S, C(Z33)(Z34), or N(Z35);
Z31 to Z35 are each independently selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, and a C1-C20 alkoxy group;
a C1-C20 alkyl group and a C1-C20 alkoxy group, each substituted with at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, and a phosphoric acid or a salt thereof;
a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a triazinyl group a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, and a dibenzocarbazolyl group;
a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a triazinyl group a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, and a dibenzocarbazolyl group, each substituted with at least one selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, and a naphthyl group; and
\u2014Si(Q31)(Q32)(Q33);
wherein Q31 to Q33 are each independently selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and a triazinyl group;
e1 is an integer selected from 1 to 5;
e2 is an integer selected from 1 to 7;
e3 is an integer selected from 1 to 3;
e4 is an integer selected from 1 to 4;
e5 is 1 or 2; and
* indicates a binding site with an adjacent atom.
9. The condensed cyclic compound as claimed in claim 1, wherein
Ar1 to Ar8 in Formula 1 are each independently selected from Formulae 6-1 to 6-28:
in Formulae 6-1 to 6-28, * indicates a binding site with an adjacent atom.
10. The condensed cyclic compound as claimed in claim 1, wherein
X4 is R4, and b1+b2+b3=2.
11. The condensed cyclic compound as claimed in claim 1, wherein
X4 is R4, and
b1=b2=1, and b3=0;
b1=b3=1, and b2=0; or
b2=b3=1, and b1=0.
12. The condensed cyclic compound as claimed in claim 1, wherein
R1 to R4 in Formula 1 are each independently selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and \u2014Si(Q1)(Q2)(Q3); and
R5 and R6 in Formula 1 are each independently selected from a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group.
13. The condensed cyclic compound as claimed in claim 1, wherein
the condensed cyclic compound is represented by any one selected from Formulae 1-1 to 1-5 below:
wherein X1 to X3, R1 to R6, and c1 to c3 in Formulae 1-1 to 1-5 are the same as defined in claim 1.
14. The condensed cyclic compound as claimed in claim 1, wherein
the condensed cyclic compound is represented by any one selected from Formulae 1-21 to 1-24:
wherein L1, L2, Ar1 to Ar4, and c1 to c3 in Formulae 1-21 to 1-24 are the same as defined in claim 1;
R1 to R4 are each independently selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and \u2014Si(Q1)(Q2)(Q3); and
R5 and R6 are each independently selected from a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group.
15. The condensed cyclic compound as claimed in claim 1, wherein
the condensed cyclic compound is represented by Formula 1-31 or 1-32 below:
wherein L1, L2, and Ar1 to Ar4 in Formulae 1-31 and 1-32 are the same as defined in claim 1;
R4 is selected from a hydrogen, a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and \u2014Si(Q1)(Q2)(Q3);
R5 and R6 are each independently selected from a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; and
a1 and a2 are each independently 0 or 1.
16. The condensed cyclic compound as claimed in claim 1, wherein
the condensed cyclic compound is any one selected from Compounds 1 to 373 below:
17. An organic light-emitting device, comprising:
a first electrode;
a second electrode facing the first electrode; and
an organic layer between the first electrode and the second electrode, the organic layer including an emission layer;
wherein the organic layer includes at least one condensed cyclic compound as claimed in claim 1.
18. The organic light-emitting device as claimed in claim 17, wherein
the first electrode is an anode,
the second electrode is a cathode,
and the organic layer includes
i) a hole transport region between the first electrode and the emission layer, the hole transport region including at least one selected from a hole injection layer, a hole transport layer, a buffer layer, and an electron blocking layer, and
ii) an electron transport region between the emission layer and the second electrode, the electron transport region including at least one selected from a hole blocking layer, an electron transport layer, and an electron injection layer.
19. The organic light-emitting device as claimed in claim 17, wherein
the emission layer includes the condensed cyclic compound.
20. The organic light-emitting device as claimed in claim 19, wherein
the emission layer further includes a compound represented by Formula 301:
Ar301-(L301)xb1-R301xb2\u2003\u2003<Formula 301\u2267
wherein in Formula 301,
Ar301 is selected from
a naphthalene, a heptalene, a fluorenene, a spiro-fluorene, a benzofluorene, a dibenzofluorene, a phenalene, a phenanthrene, an anthracene, a fluoranthene, a triphenylene, a pyrene, a chrysene, a naphthacene, a picene, a perylene, a pentaphene, and an indenoanthracene; and
a naphthalene, a heptalene, a fluorene, a spiro-fluorene, a benzofluorene, a dibenzofluorene, a phenalene, a phenanthrene, an anthracene, a fluoranthene, a triphenylene, a pyrene, a chrysene, a naphthacene, a picene, a perylene, a pentaphene, and an indenoanthracene, each substituted with at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10cycloalkyl group, a C2-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C2-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C2-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, and \u2014Si(Q301)(Q302)(Q303), wherein Q301 to Q303 are each independently selected from a hydrogen, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C6-C60 aryl group, and a C2-C60 heteroaryl group;
L301 is selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C2-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C2-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C60 arylene group, a substituted or unsubstituted C2-C60 heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group;
R301 is selected from
a C1-C20 alkyl group and a C1-C20 alkoxy group;
a C1-C20 alkyl group and a C1-C20 alkoxy group, each substituted with at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and a triazinyl group;
a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazole group, and a triazinyl group; and
a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and a triazinyl group, each substituted with at least one selected from a deuterium, \u2014F, \u2014Cl, \u2014Br, \u2014I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and a triazinyl group;
xb1 is selected from 0, 1, 2, and 3; and
xb2 is selected from 1, 2, 3, and 4.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. In a linear minimum mean-square error receiver, a method of providing optimal linear estimates of a plurality of symbol substreams comprising:
computing a first observation vector, R0,1, by correlating a set of delayed versions of a received signal with a long spreading code and a first walsh code;
computing a second observation vector, R1,1, by correlating the set of delayed versions of the received signal with the long spreading code and a second walsh code;
computing a first inner product of a vertical concatenation of the first and second observation vectors with a first receiver vector to produce a first symbol estimate; and
computing a second inner product of the vertical concatenation of the first and second observation vectors with a second receiver vector to produce a second symbol estimate.
2. The method of claim 1 wherein computation of the first receiver vector comprises:
computing a correlation matrix \u0393Q defined by
\u0393
Q
=
E
\u2062
{
\u2003
\u2062
R
0
\u2062
R
0
H
R
0
\u2062
R
1
T
R
1
*
\u2062
R
0
H
R
1
*
\u2062
R
1
T
\u2062
\u2003
}
;
and
computing a product of an inverse of the correlation matrix and a vertical concatenation of two channel vectors, f0 and f1*, to yield
v
MMSE_s
0
=
\u0393
–
1
N
\u2062
\u2003
\u2062
I
o
\u2062
\u2003
\u2062
r
\u221d
\u2003
\u2062
\u03a9
–
1
0
0
(
\u03a9
–
1
)
\u2062
\u2003
\u2062
\u2003
\u2003
\u2062
f
0
f
1
*
\u2062
\u2003
wherein N denotes the length of this code, lor denotes the power per chip received from the serving base station, \u03a9 denotes the normalized covariance matrix for both R0 and R1, E is the evaluation of the mean and covariance of the observation vectors R0 and R1.
3. The method of claim 1 wherein computation of the second receiver vector comprises:
computing a correlation matrix, \u0393Q, defined by
v
MMSE_s
0
=
\u0393
–
1
N
\u2062
\u2003
\u2062
I
o
\u2062
\u2003
\u2062
r
\u221d
\u2003
\u2062
\u03a9
–
1
0
0
(
\u03a9
–
1
)
\u2062
\u2003
\u2062
\u2003
\u2003
\u2062
f
0
f
1
*
\u2062
\u2003
and
computing a product of an inverse of the correlation matrix and a vertical concatenation of two channel vectors f1 and f0* to yield
v
MMSE_s
0
=
\u0393
–
1
N
\u2062
\u2003
\u2062
I
o
\u2062
\u2003
\u2062
r
\u221d
\u2003
\u2062
\u03a9
–
1
0
0
(
\u03a9
–
1
)
\u2062
\u2003
\u2062
\u2003
\u2003
\u2062
f
1
–
f
0
*
\u2062
\u2003
wherein N denotes the length of this code, lor denotes the power per chip received from the serving base station, \u03a9 denotes the normalized covariance matrix for both R0 and R1, E is the evaluation of the mean and covariance of the observation vectors R0 and R1.
4. The method of claim 1 wherein the first observation vector is defined by
R
0
,
i
=
\u2211
i
=
1
N
\u2062
r
i
+
1
\u2062
c
i
*
\u2062
w
i
,
wherein c is the long spreading code, w is the walsh code, r is the received signal, N is a number of chips per walsh code and l is an index within the first observation vector.
5. The method of claim 1 wherein the second observation vector is defined by
R
1
,
i
=
\u2211
i
=
1
N
\u2062
r
N
+
i
+
1
\u2062
c
N
+
i
*
\u2062
w
i
,
wherein c is the long spreading code, w is the walsh code, r is the received signal, N is a number of chips per walsh code and l is an index within the second observation vector.
6. The method of claim 1 wherein the first observation vector is defined by
R
0
,
i
=
\u2211
i
=
1
2
,
N
\u2062
r
i
+
1
\u2062
c
i
*
\u2062
w
i
0
=
\u2211
i
=
1
N
\u2062
r
i
+
1
\u2062
c
i
*
\u2062
w
i
–
\u2211
i
=
1
N
\u2062
r
N
+
i
+
1
\u2062
c
N
+
i
*
\u2062
w
i
,
wherein c is the long spreading code, w0 is a first extended walsh code, w is the walsh code, r is the received signal, N is a number of chips per walsh code and l is an index within the first observation vector.
7. The method of claim 1 wherein the second observation vector is defined by
R
1
,
i
=
\u2211
i
=
1
2
,
N
\u2062
r
i
+
1
\u2062
c
i
*
\u2062
w
i
1
=
\u2211
i
=
1
N
\u2062
r
i
+
1
\u2062
c
i
*
\u2062
w
i
–
\u2211
i
=
1
N
\u2062
r
N
+
i
+
1
\u2062
c
N
+
i
*
\u2062
w
i
,
wherein c is the long spreading code, w1 is a second extended walsh code, w is the walsh code, r is the received signal, N is a number of chips per walsh code and l is an index within the second observation vector.
8. In a linear minimum mean-square error receiver, a method of providing optimal linear estimates of a plurality of symbol substreams comprising:
filtering a received signal with a time reverse of an upper component, \u03a9\u22121f0, of a receiver vector,
v
MMSE_s
0
=
\u0393
–
1
N
\u2062
\u2003
\u2062
I
o
\u2062
\u2003
\u2062
r
\u221d
\u2003
\u2062
\u03a9
–
1
0
0
(
\u03a9
–
1
)
*
\u2062
\u2003
\u2062
\u2003
\u2003
\u2062
f
0
f
1
*
\u2062
\u2003
=
\u2003
\u2062
\u03a9
–
1
\u2062
f
0
(
\u03a9
–
1
)
*
\u2062
f
1
*
\u2062
\u2003
to yield a first output;
filtering the received signal with a time reverse of a lower component, (\u03a9\u22121)*f1*, of the receiver vector,
v
MMSE_s
0
=
\u0393
–
1
N
\u2062
\u2003
\u2062
I
o
\u2062
\u2003
\u2062
r
\u221d
\u2003
\u2062
\u03a9
–
1
0
0
(
\u03a9
–
1
)
*
\u2062
\u2003
\u2062
\u2003
\u2003
\u2062
f
0
f
1
*
\u2062
\u2003
=
\u2003
\u2062
\u03a9
–
1
\u2062
f
0
(
\u03a9
–
1
)
*
\u2062
f
1
*
\u2062
\u2003
to yield a second output wherein f0 and f1 are two channel vectors, N denotes the length of this code, lor denotes the power per chip received from the serving base station, \u03a9 denotes the normalized covariance matrix for both R0 and R1, E is the evaluation of the mean and covariance of the observation vectors R0 and R1, \u0393Q denotes the correlation matrix
correlating the first output with a product of a complex conjugate of a long spreading code and a first extended walsh code to yield a third output;
correlating the first output with a product of the complex conjugate of the long spreading code and a second extended walsh code to yield a fourth output;
correlating the second output with the product of the complex conjugate of the long spreading code and the first extended walsh code to yield a fifth output;
correlating the second output with the product of the complex conjugate of the long spreading code and the second extended walsh code to yield a sixth output;
summing the third output and a complex conjugate of the sixth output to yield a first symbol estimate; and
subtracting a complex conjugate of the fourth output from the fifth output to yield a second symbol estimate.
9. The method of claim 8 further comprising:
correlating the first output with a product of the complex conjugate of the long spreading code and a first pilot walsh to yield a seventh output;
correlating the second output with a product of the complex conjugate of the long spreading code and a second pilot walsh to yield an eigth output;
summing the seventh output and complex conjugate of the eigth output to yield a ninth output;
subtracting 1 from the ninth output to yield an error measure.
10. The method of claim 9 further comprising using the error measure to adapt an estimate of the upper and lower components of the receiver vector.
11. The method of claim 9 further comprising:
computing a magnitude square of the error measure;
low pass filtering the magnitude square of the error measure;
computing an inverse of the filtered magnitude square of the error measure; and
providing the computed inverse to a soft decision decoder as a measure of reliability.
12. In a linear minimum mean-square error receiver, a method of providing optimal linear estimates of a plurality of symbol substreams comprising:
filtering a received signal with a time reverse of an upper component, \u03a9\u22121f0, of a receiver vector,
v
MMSE_s
0
=
\u0393
–
1
N
\u2062
\u2003
\u2062
I
o
\u2062
\u2003
\u2062
r
\u221d
\u2003
\u2062
\u03a9
–
1
0
0
(
\u03a9
–
1
)
*
\u2062
\u2003
\u2062
\u2003
\u2003
\u2062
f
0
f
1
*
\u2062
\u2003
=
\u2003
\u2062
\u03a9
–
1
\u2062
f
0
(
\u03a9
–
1
)
*
\u2062
f
1
*
\u2062
\u2003
to produce a first output
filtering the received signal with a time reverse of a lower component, (\u03a9\u22121)*f1*, of the receiver vector,
v
MMSE_s
0
=
\u0393
–
1
N
\u2062
\u2003
\u2062
I
o
\u2062
\u2003
\u2062
r
\u221d
\u2003
\u2062
\u03a9
–
1
0
0
(
\u03a9
–
1
)
*
\u2062
\u2003
\u2062
\u2003
\u2003
\u2062
f
0
f
1
*
\u2062
\u2003
=
\u2003
\u2062
\u03a9
–
1
\u2062
f
0
(
\u03a9
–
1
)
*
\u2062
f
1
*
\u2062
\u2003
to produce a second output wherein f0 and f1 are two channel vectors, N denotes the length of this code, lor denotes the power per chip received from the serving base station, \u03a9 denotes the normalized covariance matrix for both R0 and R1, E is the evaluation of the mean and covariance of the observation vectors R0 and R1, \u0393Q denotes the correlation matrix
correlating the first output with a product of a complex conjugate of a long spreading code and a walsh code to yield a first output sequence;
correlating the second output with the product of the complex conjugate of the long spreading code and the walsh code to yield a second output sequence;
summing a complex conjugate of a current output of the second output sequence with a previous output of the first output sequence to yield a first symbol estimate; and
subtracting a complex conjugate of a current output of the first output sequence from a previous output of the second output sequence to yield a second symbol estimate.
13. The method of claim 12 further comprising:
correlating the first output with a product of the complex conjugate of the long spreading code and a first pilot walsh to yield a third output sequence;
correlating the second output with a product of the complex conjugate of the long spreading code and a second pilot walsh to yield a fourth output sequence;
summing the third output sequence and a complex conjugate of the fourth output sequence to yield a fifth output sequence; and
subtracting 1 from the fifth output sequence to yield an error measure.
14. The method of claim 13 further comprising using the error measure to adapt an estimate of the upper and lower components of the receiver vector.
15. The method of claim 13 further comprising:
computing a magnitude square of the error measure;
low pass filtering the magnitude square of the error measure;
computing an inverse of the filtered magnitude square of the error measure; and
providing the computed inverse to a soft decision decoder as a measure of reliability.